Patient-derived xenografts as preclinical neuroblastoma models.
Cell Tissue Res. 2017 Sep 19;:
Authors: Braekeveldt N, Bexell D
Abstract The prognosis for children with high-risk neuroblastoma is often poor and survivors can suffer from severe side effects. Predictive preclinical models and novel therapeutic strategies for high-risk disease are therefore a clinical imperative.